(Q77823356)
Statements
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton (English)
Vidya Soerdjbalie-Maikoe
Guus A B Lycklama à Nijeholt
Jan-Willem Arndt
Aeilko H Zwinderman
Socrates E Papapoulos
Neveen A T Hamdy
15 February 2002